Wei, Jun <br/><br/>
A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.  [electronic resource] 

 -  Annals of the rheumatic diseases  Feb 2014 
 - 446-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/annrheumdis-2012-202716  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipogenesis--drug effects<br/>Adult<br/>Animals<br/>Biopsy<br/>Cells, Cultured<br/>Collagen--biosynthesis<br/>Disease Models, Animal<br/>Drug Evaluation, Preclinical--methods<br/>Female<br/>Fibroblasts--drug effects<br/>Fibrosis<br/>Humans<br/>Infant, Newborn<br/>Mice<br/>Mice, Inbred C57BL<br/>Oleanolic Acid--analogs & derivatives<br/>Organ Culture Techniques<br/>PPAR gamma--agonists<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Scleroderma, Systemic--drug therapy<br/>Signal Transduction--drug effects<br/>Skin--drug effects<br/>Transforming Growth Factor beta--antagonists & inhibitors